Over the past few years, knowledge regarding the molecular pathology of sporadic
pancreatic neuroendocrine tumors (PNETs) has increased substantially, and a number of …

Introduction: Pancreatic neuroendocrine tumors (pNETs) represent a small part of pancreatic
neoplasms, and the knowledge about their indolent clinical course remains a subject of …

Pancreatic neuroendocrine tumors (PNETs) are rare primary neoplasms of the pancreas
and arise sporadically or in the context of genetically determined syndromes. Depending on …

Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Pancreatic neuroendocrine tumors (PNETs) share a unique genetic identity, functional
behavior, and clinical course. Compared with tumors of the exocrine pancreas, they are rare …

Well-differentiated pancreatic neuroendocrine tumors (PanNETs) comprise∼ 1–3% of
pancreatic neoplasms. Although long considered as reasonably benign lesions, PanNETs …

Pancreatic neuroendocrine neoplasms (panNENs) are the second most common epithelial
tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it …

Pancreatic neuroendocrine tumors (PNETs), a group of endocrine tumors arising in the
pancreas, are among the most common neuroendocrine tumors. The genetic causes of …

Pancreatic neuroendocrine tumors (pNETs) are a group of heterogeneous tumors originated
from progenitor cells. As these tumors are predominantly non-functional, most of them …

Pancreatic neuroendocrine tumors (PNET) are rare tumors, but have been increasing in
incidence. Although typically thought of as indolent, more than half of patients present with …